Gut microbiota and postpartum depression: a Mendelian randomization study

Jianjun Zhang1,2, Lechuan Wei3, Hongfei Tan3

  • 1Department of Obstetrics, Affiliated Hospital of Weifang Medical University, Weifang, China.

PubMed
Abstract

Insights

Gut bacteria like Actinobacteria and Holdemanella may protect against postpartum depression (PPD). This Mendelian randomization study suggests a causal link, paving the way for new PPD treatments.

Area of Science:

  • Microbiome research
  • Gut-brain axis studies
  • Mental health research

Background:

  • The gut-brain axis links intestinal microbiota to neurological function.
  • A clear causal relationship between gut microbiota and postpartum depression (PPD) is not yet established.
  • Understanding this connection is crucial for developing novel PPD therapeutic strategies.

Purpose of the Study:

  • To investigate the potential causal relationship between specific gut microorganisms and postpartum depression (PPD).
  • To utilize Mendelian randomization (MR) to analyze genetic associations between gut microbiota and PPD.
  • To identify specific bacterial taxa that may influence PPD risk.

Main Methods:

  • Employed a two-sample Mendelian randomization (MR) design.
  • Analyzed genome-wide association study (GWAS) data for gut microorganisms (Mibiogen) and PPD (UK Biobank).
  • Utilized multiple statistical methods (IVW, MR-Egger, weighted median, etc.) and sensitivity analyses to ensure result robustness.

Main Results:

  • Phylum Actinobacteria and genus Holdemanella showed a protective effect against PPD (P<0.05).
  • Two unidentified genera (Unknown Ids 2001 and 2755) also demonstrated a protective association with PPD (P<0.05).
  • Sensitivity analyses confirmed no significant heterogeneity or horizontal pleiotropy, supporting the causal findings.

Conclusions:

  • Established a potential causal association between Actinomycetota, Holdemanella, and PPD.
  • Findings suggest that specific gut bacteria may play a protective role in PPD.
  • Results support the development of personalized PPD treatments, including dietary and microbiome interventions.